(19)
(11) EP 3 164 112 A1

(12)

(43) Date of publication:
10.05.2017 Bulletin 2017/19

(21) Application number: 15741430.1

(22) Date of filing: 02.07.2015
(51) International Patent Classification (IPC): 
A61K 9/127(2006.01)
A61K 47/50(2017.01)
(86) International application number:
PCT/US2015/039004
(87) International publication number:
WO 2016/004318 (07.01.2016 Gazette 2016/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 02.07.2014 US 201462020163 P

(71) Applicant: Shire Human Genetic Therapies, Inc.
Lexington, MA 02421 (US)

(72) Inventors:
  • DEROSA, Frank
    Lexington, Massachusetts 02421 (US)
  • KARVE, Shrirang
    Lexington, Massachusetts 02421 (US)
  • HEARTLEIN, Michael
    Lexington, Massachusetts 02421 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) ENCAPSULATION OF MESSENGER RNA